Why is market access no longer a nice to know but a must-have skill for pharma professionals today?

Описание: 𝐖𝐡𝐚𝐭 𝐢𝐟 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐝𝐢𝐝𝐧’𝐭 𝐡𝐚𝐯𝐞 𝐭𝐨 𝐩𝐚𝐲 𝐟𝐨𝐫 𝐜𝐚𝐧𝐜𝐞𝐫 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐨𝐮𝐭 𝐨𝐟 𝐩𝐨𝐜𝐤𝐞𝐭?

In countries like 𝐈𝐭𝐚𝐥𝐲, 𝐩𝐮𝐛𝐥𝐢𝐜 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐜𝐨𝐯𝐞𝐫𝐬 𝐧𝐞𝐚𝐫𝐥𝐲 𝐞𝐯𝐞𝐫𝐲𝐭𝐡𝐢𝐧𝐠 — from high-cost treatments to everyday care. But in India, it's a different story: 𝐨𝐮𝐭-𝐨𝐟-𝐩𝐨𝐜𝐤𝐞𝐭 𝐬𝐩𝐞𝐧𝐝𝐢𝐧𝐠 𝐝𝐨𝐦𝐢𝐧𝐚𝐭𝐞𝐬, and access often depends on affordability.

🎙 In this byte, 𝑴𝒓. 𝑨𝒔𝒉𝒊𝒔 𝑴𝒖𝒌𝒉𝒆𝒓𝒋𝒆𝒆 (VP & Global Head, Market Access & Reimbursement – Menarini Group) shares how 𝐦𝐚𝐫𝐤𝐞𝐭 𝐚𝐜𝐜𝐞𝐬𝐬 𝐢𝐬 𝐧𝐨 𝐥𝐨𝐧𝐠𝐞𝐫 𝐚 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐟𝐮𝐧𝐜𝐭𝐢𝐨𝐧 — 𝐢𝐭’𝐬 𝐛𝐞𝐜𝐨𝐦𝐢𝐧𝐠 𝐚 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐦𝐮𝐬𝐭-𝐡𝐚𝐯𝐞.

⚙ Global pharma companies are building 𝐬𝐭𝐫𝐨𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 𝐚𝐜𝐜𝐞𝐬𝐬 𝐭𝐞𝐚𝐦𝐬
📊 India is now actively exploring 𝐇𝐓𝐀 𝐟𝐫𝐚𝐦𝐞𝐰𝐨𝐫𝐤𝐬
👉 𝐈𝐬 𝐈𝐧𝐝𝐢𝐚 𝐫𝐞𝐚𝐝𝐲 𝐭𝐨 𝐦𝐨𝐯𝐞 𝐟𝐫𝐨𝐦 𝐩𝐫𝐢𝐯𝐚𝐭𝐞 𝐛𝐮𝐫𝐝𝐞𝐧 𝐭𝐨 𝐩𝐮𝐛𝐥𝐢𝐜 𝐬𝐮𝐩𝐩𝐨𝐫𝐭?

🎥 Watch the full podcast to stay ahead of the curve.
𝐋𝐢𝐧𝐤:    • Episode 6: From Pills to Policy: Why Marke...  



#MarketAccess #PharmaPricing #HEOR #ValueBasedCare #AshisMukherjee #PharmaLeadership #DrugPricing #PharmaStrategy #HumansOfPharma #PharmaBytes #PharmaStateAcademy